Pharmacogenetics from ethno-cultural perspectives

Advances in genetic technology have focussed on how genetic polymorphisms may impact on drug metabolism, response, adverse effects and clinical outcome. As drug handling and response is significantly driven by genetic factors, genotyping holds promise for personalised medicines. However, high geneti...

Full description

Bibliographic Details
Main Authors: Chee Ng, David Castle
Format: Article
Language:English
Published: Sri Lanka College of Psychiatrists 2010-12-01
Series:Sri Lanka Journal of Psychiatry
Subjects:
Online Access:https://sljpsyc.sljol.info/articles/2569
id doaj-fa3271865295421fa6d59197cb2a32b3
record_format Article
spelling doaj-fa3271865295421fa6d59197cb2a32b32021-04-08T06:23:44ZengSri Lanka College of PsychiatristsSri Lanka Journal of Psychiatry2012-68832579-20082010-12-0112293110.4038/sljpsyc.v1i2.25692168Pharmacogenetics from ethno-cultural perspectivesChee Ng0David Castle1Department of Psychiatry, University of Melbourne, Director, International Unit, St Vincent’s Mental Health; and Deputy Director, Professorial Unit, The Melbourne ClinicChair of Psychiatry, St Vincent’s Hospital, University of Melbourne.Advances in genetic technology have focussed on how genetic polymorphisms may impact on drug metabolism, response, adverse effects and clinical outcome. As drug handling and response is significantly driven by genetic factors, genotyping holds promise for personalised medicines. However, high genetic variability and multiple drug effects present a significant challenge to provide useful guidelines in clinical practice. In addition, the expressions of polymorphic genes that control neurobiological functions and drug metabolising enzymes are also influenced by environmental and dietary factors. With the increasing accessibility and affordability of genotyping, predicting clinical efficacy and adverse effects in individuals from diverse backgrounds holds greater potential. Further research into the pharmacogenetic differences from cross-ethnic perspectives may increase our understanding of the effects of genetic variants on drug efficacy and tolerability. This is likely to enable more rational psychopharmacotherapy that can minimize adverse effects, enhance efficacy, improve adherence and save costs in the long term. <br /><br />DOI: 10.4038/sljpsyc.v1i2.2569<br /><br />SL J Psychiatry 2010; 1 (2):29-31https://sljpsyc.sljol.info/articles/2569pharmacogenetics
collection DOAJ
language English
format Article
sources DOAJ
author Chee Ng
David Castle
spellingShingle Chee Ng
David Castle
Pharmacogenetics from ethno-cultural perspectives
Sri Lanka Journal of Psychiatry
pharmacogenetics
author_facet Chee Ng
David Castle
author_sort Chee Ng
title Pharmacogenetics from ethno-cultural perspectives
title_short Pharmacogenetics from ethno-cultural perspectives
title_full Pharmacogenetics from ethno-cultural perspectives
title_fullStr Pharmacogenetics from ethno-cultural perspectives
title_full_unstemmed Pharmacogenetics from ethno-cultural perspectives
title_sort pharmacogenetics from ethno-cultural perspectives
publisher Sri Lanka College of Psychiatrists
series Sri Lanka Journal of Psychiatry
issn 2012-6883
2579-2008
publishDate 2010-12-01
description Advances in genetic technology have focussed on how genetic polymorphisms may impact on drug metabolism, response, adverse effects and clinical outcome. As drug handling and response is significantly driven by genetic factors, genotyping holds promise for personalised medicines. However, high genetic variability and multiple drug effects present a significant challenge to provide useful guidelines in clinical practice. In addition, the expressions of polymorphic genes that control neurobiological functions and drug metabolising enzymes are also influenced by environmental and dietary factors. With the increasing accessibility and affordability of genotyping, predicting clinical efficacy and adverse effects in individuals from diverse backgrounds holds greater potential. Further research into the pharmacogenetic differences from cross-ethnic perspectives may increase our understanding of the effects of genetic variants on drug efficacy and tolerability. This is likely to enable more rational psychopharmacotherapy that can minimize adverse effects, enhance efficacy, improve adherence and save costs in the long term. <br /><br />DOI: 10.4038/sljpsyc.v1i2.2569<br /><br />SL J Psychiatry 2010; 1 (2):29-31
topic pharmacogenetics
url https://sljpsyc.sljol.info/articles/2569
work_keys_str_mv AT cheeng pharmacogeneticsfromethnoculturalperspectives
AT davidcastle pharmacogeneticsfromethnoculturalperspectives
_version_ 1721535346265554944